Tag: Covid-19
-
Covid-19 Antibody Therapy Trial Underway
A clinical trial of neutralizing antibodies to treat Covid-19 infections began testing the therapy with hospitalized patients in New York and Los Angeles.
-
Infographic – Major Cities Far Short of Herd Immunity
The data show in major American and European cities, as well as Wuhan, China, the percentage of the population with antibodies against the coronavirus.
-
Drug Added to Covid-19 Lung Disease Trial
A clinical trial evaluating numerous therapies for a serious lung complication of Covid-19 infections is adding a drug to treat glaucoma to the study.
-
Antibody Drug Biotech Raises $105M in Venture Funds
A company that says it has a faster process for discovering therapeutic antibodies is raising $105 million in its second venture finance round.
-
Merck Inks Three Covid-19 Vaccine, Therapy Deals
Drug maker Merck today gained a new acquisition, along with collaboration and licensing deals, for vaccines and a therapy for Covid-19 infections.
-
Covid-19 Therapies Designed with Virtual Reality, A.I.
Two companies are using deep learning and virtual reality to design treatments for Covid-19 infections, attacking a different target than most drugs being developed.
-
GSK, Biotech Partner on Crispr Covid-19 Test
A biotechnology company using gene editing for diagnostics is developing a fast, point-of-care Covid-19 test with drug maker GlaxoSmithKline.
-
Covid-19 Vaccine Produces Antibodies in Preclinical Test
Tests with lab animals show a Covid-19 vaccine now in clinical trials produces neutralizing antibodies to prevent coronavirus infections.
-
Venture Producing Covid-19 Antibody Test Kits
A new company formed from a medical research lab is producing test kits for detecting and measuring a person’s Covid-19 antibodies.
-
FDA Analyzing Real-World Evidence on Covid-19
The Food and Drug Administration is analyzing collections of health records to gain more evidence-based insights into the course of the Covid-19 pandemic.